Clinical Trial Update: A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2) [Phase 2]

View source ↗

Summary

This entry notes a Phase 2 clinical trial evaluating TAK-360 in adults with Narcolepsy Type 2 without cataplexy, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy Type

Drugs mentioned

• TAK-360

Snippet

Sponsor: Takeda | Conditions: Narcolepsy Type 2 | Phase 2 | Status: RECRUITING